Drug Shortage Report for ACT ETIDROCAL
| Report ID | 57207 |
| Drug Identification Number | 02263866 |
| Brand name | ACT ETIDROCAL |
| Common or Proper name | ETIDROCAL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ETIDRONATE DISODIUM CALCIUM |
| Strength(s) | 400MG 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90 |
| ATC code | M05BB |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-05-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2019-02-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-08-01 | English | Compare |
| v2 | 2018-08-01 | French | Compare |
| v3 | 2018-10-11 | English | Compare |
| v4 | 2018-10-11 | French | Compare |
| v5 | 2018-11-20 | English | Compare |
| v6 | 2018-11-20 | English | Compare |
| v7 | 2018-11-20 | French | Compare |
| v8 | 2018-12-04 | English | Compare |
| v9 | 2018-12-04 | French | Compare |
| v10 | 2019-01-03 | English | Compare |
| v11 | 2019-01-03 | French | Compare |
| v12 | 2019-01-31 | English | Compare |
| v13 | 2019-01-31 | French | Compare |
| v14 | 2019-02-21 | English | Compare |
| v15 | 2019-02-21 | English | Compare |
| v16 | 2019-02-21 | French | Compare |
Showing 1 to 16 of 16